May 15, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
PHOENIX — Results presented here showed cryopreserved osteochondral allografts had similar outcomes compared with fresh osteochondral allografts in patients with isolated patellofemoral lesions.“These cryopreserved osteochondral allografts allow the surgeon to have an off-the-shelf option for when they are dealing with these high-level cartilage lesions of the patellofemoral joint,
May 15, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

A Zillow-like marketplace for abandoned gene therapies goes live

Integrated CDO capabilities reduce early development complexity

Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial

Advancing Frontline Care With a Quadruplet Regimen for Transplant-Ineligible Myeloma Patients

ASGCT dispatch: In vivo CAR-T is everywhere

Targeted Protein Degradation and Novel Modalities: Getting on the Frontline

Astellas treatment offers new hope to a devastated rare disease community

A Series A, B and an IPO; Cabaletta reports CAR-T results

Five years after disaster, a rare disease community gets new chance at treatment

BeOne wins FDA approval in lymphoma race